后颅窝脑肿瘤儿童幸存者领域特异性神经认知结局的危险因素——HIT 2000试验结果
该研究分析HIT-2000试验中279例无复发后颅窝肿瘤幸存者(241例髓母细胞瘤、38例幕下室管膜瘤)的领域特异性神经认知结局,发现诊断后平均5.14年时所有分测验认知表现均显著低于正常,处理速度与精神运动能力受损最重,颅脊照射剂量对多数分测验有强影响。
要点
- 诊断后平均5.14年时所有神经认知分测验均显著低于正常,处理速度和精神运动能力受损最重。
- 颅脊照射剂量对多数分测验有强影响;术后小脑缄默综合征与精神运动能力(β=-0.25至-0.16)和处理速度(β=-0.32)相关。
- 术后脑积水与晶体智力(β=-0.20)和短时记忆(β=-0.15)相关;随诊断后时间延长,流体智力、短时记忆和视觉处理下降,选择性注意改善。
核心结论
- 颅脊照射剂量与神经认知结局强相关;接受和未接受颅脊照射患者均表现低精神运动能力和处理速度,提示肿瘤本身及其手术对这些功能有重要影响。
- 未来研究应分析降低颅脊照射剂量和其他治疗方式所致毒性的策略。
研究设计与样本
- 分析HIT-2000试验中279例无复发后颅窝肿瘤幸存者(241例髓母细胞瘤、38例幕下室管膜瘤)的领域特异性神经认知结局数据,采用基于Cattell-Horn-Carroll智力模型的神经心理基本诊断工具。
主要发现
- 诊断后平均5.14年(范围1.52-13.02年)时所有分测验认知表现均显著低于正常,处理速度和精神运动能力受损最重。
- 颅脊照射剂量对多数分测验有强影响;术后小脑缄默综合征与精神运动能力(β=-0.25至-0.16)和处理速度(β=-0.32)相关。
- 术后脑积水与晶体智力(β=-0.20)和短时记忆(β=-0.15)相关;年龄与晶体智力(β=0.15)和精神运动能力(β=-0.16和β=-0.17)相关。
- 随诊断后时间延长,流体智力(β=-0.23)、短时记忆(β=-0.17)和视觉处理(β=-0.25)评分下降,选择性注意评分改善(β=0.29)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neurocognition can be severely affected in pediatric brain tumor survivors. We analyzed the association of cognitive functioning with radiotherapy dose, postoperative cerebellar mutism syndrome (pCMS), hydrocephalus, intraventricular methotrexate (MTX) application, tumor localization, and biology in pediatric survivors of a posterior fossa tumor. METHODS: Subdomain-specific neurocognitive outcome data from 279 relapse-free survivors of the HIT-2000 trial (241 medulloblastoma and 38 infratentorial ependymoma) using the Neuropsychological Basic Diagnostic tool based on Cattell-Horn-Carroll's model for intelligence were analyzed. RESULTS: Cognitive performance 5.14 years (mean; range = 1.52-13.02) after diagnosis was significantly below normal for all subtests. Processing speed and psychomotor abilities were most affected. Influencing factors were domain-specific: CSI-dose had a strong impact on most subtests. pCMS was associated with psychomotor abilities (β = -0.25 to -0.16) and processing speed (β = -0.32). Postoperative hydrocephalus correlated with crystallized intelligence (β = -0.20) and short-term memory (β = -0.15), age with crystallized intelligence (β = 0.15) and psychomotor abilities (β = -0.16 and β = -0.17). Scores for fluid intelligence (β = -0.23), short-term memory (β = -0.17) and visual processing (β = -0.25) declined, and scores for selective attention improved (β = 0.29) with time after diagnosis. CONCLUSIONS: The dose of CSI was strongly associated with neurocognitive outcomes. Low psychomotor abilities and processing speed both in patients treated with and without CSI suggest a strong contribution of the tumor and its surgery on these functions. Future research therefore should analyze strategies to both reduce CSI dose and toxicity caused by other treatment modalities.
引用
- Mynarek M, Rossius A, Guiard A, et al. Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial. Neuro Oncol. 2024. PMID: 38835160. doi:10.1093/neuonc/noae092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。